Evidence map›Paper›PMID 36416085›Full record

ArticleThe EMBO journal2023

A Zn-dependent structural transition of SOD1 modulates its ability to undergo phase separation.

Bidisha Das, Sumangal Roychowdhury, Priyesh Mohanty, Azamat Rizuan, Joy Chakraborty, Jeetain Mittal, Krishnananda Chattopadhyay

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Client-scaffold interactions suppress aggregation of a client protein in model condensates.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Neurological Diseases can be Regulated by Phase Separation.Reviews of physiology, biochemistry and pharmacology · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Bidisha Das *Structural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.ORCID 0000-0003-4491-6945
Sumangal Roychowdhury *Structural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.ORCID 0000-0002-5705-4021
Priyesh MohantyArtie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, TX, USA.ORCID 0000-0003-3919-3527
Azamat RizuanArtie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, TX, USA.ORCID 0000-0003-3590-0829
Joy ChakrabortyCell Biology and Physiology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Jeetain MittalArtie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, TX, USA.ORCID 0000-0002-9725-6402
Krishnananda ChattopadhyayStructural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.ORCID 0000-0002-1449-8909
Indian Institute of Chemical Biology · INTexas A&M University · US

Funding

Functional and Pathological Interactions of TDP-43R01NS116176 · NINDS · BROWN UNIVERSITY · PI FAWZI, NICOLAS LUX, MITTAL, JEETAIN · 2020 to 2024
$3.6M
NINDS NIH HHS R01 NS116176
6 · The paper itself

Abstract

The misfolding and mutation of Cu/Zn superoxide dismutase (SOD1) is commonly associated with amyotrophic lateral sclerosis (ALS). SOD1 can accumulate within stress granules (SGs), a type of membraneless organelle, which is believed to form via liquid-liquid phase separation (LLPS). Using wild-type, metal-deficient, and different ALS disease mutants of SOD1 and computer simulations, we report here that the absence of Zn leads to structural disorder within two loop regions of SOD1, triggering SOD1 LLPS and amyloid formation. The addition of exogenous Zn to either metal-free SOD1 or to the severe ALS mutation I113T leads to the stabilization of the loops and impairs SOD1 LLPS and aggregation. Moreover, partial Zn-mediated inhibition of LLPS was observed for another severe ALS mutant, G85R, which shows perturbed Zn-binding. By contrast, the ALS mutant G37R, which shows reduced Cu-binding, does not undergo LLPS. In addition, SOD1 condensates induced by Zn-depletion exhibit greater cellular toxicity than aggregates formed by prolonged incubation under aggregating conditions. Overall, our work establishes a role for Zn-dependent modulation of SOD1 conformation and LLPS properties that may contribute to amyloid formation.

Indexed as

Superoxide Dismutase-1ZincAmyotrophic Lateral SclerosisHumansMutationProtein FoldingSOD1 protein, humanSuperoxide Dismutase-1Zincaggregationamyotrophic lateral sclerosis (ALS)liquid-liquid phase separation (LLPS)molecular dynamics (MD) simulationSOD1

Identifiers

PMID36416085
PMCPMC9841336
OpenAlexW4309728667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.